AAAAAA
Results: 101-125/517
Authors:
ASAKURA E
YAMAUCHI T
UMEMURA A
HANAMURA T
TANABE T
Citation: E. Asakura et al., INTRAVENOUSLY ADMINISTERED MACROPHAGE-COLONY-STIMULATING FACTOR (M-CSF) SPECIFICALLY ACTS ON THE SPLEEN, RESULTING IN THE INCREASING AND ACTIVATING SPLEEN MACROPHAGES FOR CYTOKINE PRODUCTION IN MICE, Immunopharmacology, 37(1), 1997, pp. 7-14
Authors:
HANAMURA T
ASAKURA E
TANABE T
Citation: T. Hanamura et al., MACROPHAGE-COLONY-STIMULATING FACTOR (M-CSF) AUGMENTS CYTOKINE INDUCTION BY LIPOPOLYSACCHARIDE (LPS)-STIMULATION AND BY BACTERIAL-INFECTIONS IN MICE, Immunopharmacology, 37(1), 1997, pp. 15-23
Authors:
STANULIS ED
JORDAN SD
ROSECRANS JA
HOLSAPPLE MP
Citation: Ed. Stanulis et al., DISRUPTION OF TH1 TH2 CYTOKINE BALANCE BY COCAINE IS MEDIATED BY CORTICOSTERONE/, Immunopharmacology, 37(1), 1997, pp. 25-33
Authors:
MARCINKIEWICZ J
Citation: J. Marcinkiewicz, NITRIC-OXIDE AND ANTIMICROBIAL ACTIVITY OF REACTIVE OXYGEN INTERMEDIATES, Immunopharmacology, 37(1), 1997, pp. 35-41
Authors:
GRANOTH R
VADAI E
BURSTEIN Y
FRIDKIN M
TZEHOVAL E
Citation: R. Granoth et al., TUFTSIN-THF-GAMMA-2 CHIMERIC PEPTIDES - POTENTIAL NOVEL IMMUNOMODULATORS, Immunopharmacology, 37(1), 1997, pp. 43-52
Authors:
BADGER AM
NEWMANTARR TM
SATTERFIELD JL
Citation: Am. Badger et al., SELECTIVE IMMUNOMODULATORY ACTIVITY OF SK-AND-F-106615, A MACROPHAGE-TARGETING ANTIARTHRITIC COMPOUND, ON ANTIBODY AND CELLULAR-RESPONSES IN RATS AND MICE, Immunopharmacology, 37(1), 1997, pp. 53-61
Authors:
MULLINS DW
ALLEVA DG
BURGER CJ
ELGERT KD
Citation: Dw. Mullins et al., TAXOL, A MICROTUBULE-STABILIZING ANTINEOPLASTIC AGENT, DIFFERENTIALLYREGULATES NORMAL AND TUMOR-BEARING HOST MACROPHAGE NITRIC-OXIDE PRODUCTION, Immunopharmacology, 37(1), 1997, pp. 63-73
Authors:
LEYKIN I
MAYER R
SHINITZKY M
Citation: I. Leykin et al., SHORT AND LONG-TERM IMMUNOSUPPRESSIVE EFFECTS OF CLOZAPINE AND HALOPERIDOL, Immunopharmacology, 37(1), 1997, pp. 75-86
Authors:
HORIGOME A
HIRANO T
OKA K
TAKEUCHI H
SAKURAI E
KOZAKI K
MATSUNO N
NAGAO T
KOZAKI M
Citation: A. Horigome et al., GLUCOCORTICOIDS AND CYCLOSPORINE INDUCE APOPTOSIS IN MITOGEN-ACTIVATED HUMAN PERIPHERAL MONONUCLEAR-CELLS, Immunopharmacology, 37(1), 1997, pp. 87-94
Authors:
KASHIDA T
NARASAKI N
SAKAI A
TSUJIHARA K
TSUZURAHARA K
NAITO K
TAKEYAMA S
Citation: T. Kashida et al., STUDY ON THE MECHANISM OF IMMUNOPOTENTIATING ANTITUMOR EFFECT OF 6-MPG, A WATER-SOLUBLE DERIVATIVE OF 6-MERCAPTOPURINE, Immunopharmacology, 37(1), 1997, pp. 95-104
Authors:
MASUDA E
SHISHIDO T
FUJIMOTO R
MAEDA H
Citation: E. Masuda et al., CHANGES IN CELLULAR COMPOSITION INDUCED BY NEOCARZINOSTATIN PRETREATMENT IN METH A-BEARING MICE AND THE RESPONSIBLE ANTITUMOR EFFECTOR-CELLS, Immunopharmacology, 37(1), 1997, pp. 105-116
Authors:
BHOOLA K
NAIDOO Y
FRITZ H
Citation: K. Bhoola et al., KININ-96 DURBAN 20-25 OCTOBER 1996, Immunopharmacology, 36(2-3), 1997, pp. 103-104
Authors:
MULLERESTERL W
Citation: W. Mulleresterl, AWARD CEREMONY OF THE E.K.-FREY-E.-WERLE-FOUNDATION OF THE VOIGT,HENNING,L. FAMILY, Immunopharmacology, 36(2-3), 1997, pp. 105-108
Authors:
MICKE P
BLAUKAT A
MULLERESTERL W
Citation: P. Micke et al., SEARCH FOR AUTOANTIBODIES TO THE HUMAN BRADYKININ B2 RECEPTOR, Immunopharmacology, 36(2-3), 1997, pp. 109-113
Authors:
BLAUKAT A
MULLERESTERL W
Citation: A. Blaukat et W. Mulleresterl, INHIBITION OF B2 RECEPTOR INTERNALIZATION DELAYS ITS DEPHOSPHORYLATION, Immunopharmacology, 36(2-3), 1997, pp. 115-119
Authors:
CASSIM B
NAIDOO S
RAMSAROOP R
BHOOLA KD
Citation: B. Cassim et al., IMMUNOLOCALIZATION OF BRADYKININ RECEPTORS ON HUMAN SYNOVIAL TISSUE, Immunopharmacology, 36(2-3), 1997, pp. 121-125
Authors:
FIGUEROA CD
NOVOA U
VALDES G
CORTHORN J
MULLERESTERL W
Citation: Cd. Figueroa et al., LOCALIZATION OF THE BRADYKININ B2 RECEPTOR IN UTERUS, BLADDER AND MADIN-DARBY CANINE KIDNEY-CELLS, Immunopharmacology, 36(2-3), 1997, pp. 127-133
Authors:
REHBOCK J
CHONDROMATIDOU A
MISKA K
BUCHINGER P
HERMANN A
Citation: J. Rehbock et al., EVIDENCE FOR BRADYKININ B2-RECEPTORS ON CULTURED HUMAN DECIDUA CELLS, Immunopharmacology, 36(2-3), 1997, pp. 135-141
Authors:
REGOLI D
RIZZI A
CALO G
ALLOGHO SN
GOBEIL F
Citation: D. Regoli et al., B1 AND B2 KININ RECEPTORS IN VARIOUS SPECIES, Immunopharmacology, 36(2-3), 1997, pp. 143-147
Authors:
CUTHBERT AW
TEATHER S
Citation: Aw. Cuthbert et S. Teather, EXPRESSION OF BRADYKININ B1 RECEPTORS IN COLONIC EPITHELIA, Immunopharmacology, 36(2-3), 1997, pp. 149-152
Authors:
RAIDOO DM
RAMSAROOP R
NAIDOO S
MULLERESTERL W
BHOOLA KD
Citation: Dm. Raidoo et al., KININ RECEPTORS IN HUMAN VASCULAR TISSUE - THEIR ROLE IN ATHEROMATOUSDISEASE, Immunopharmacology, 36(2-3), 1997, pp. 153-160
Authors:
BHOOLA R
RAMSAROOP R
NAIDOO S
MULLERESTERL W
BHOOLA KD
Citation: R. Bhoola et al., RECEPTOR STATUS IN NORMAL AND INFLAMED GASTRIC-MUCOSA, Immunopharmacology, 36(2-3), 1997, pp. 161-165
Authors:
STEWART JM
GERA L
CHAN DC
WHALLEY ET
HANSON WL
ZUZACK JS
Citation: Jm. Stewart et al., LONG-ACTING, ORALLY-ACTIVE BRADYKININ ANTAGONISTS FOR A WIDE-RANGE OFAPPLICATIONS, Immunopharmacology, 36(2-3), 1997, pp. 167-172
Authors:
EICHRATHFELDER S
WHALLEY ET
FAUTZ M
HOHENBLEICHER F
FRITZ H
SIEBECK M
Citation: S. Eichrathfelder et al., TACHYPHYLAXIS OF THE B1 KININ RECEPTOR IN PORCINE ENDOTOXIN-SHOCK, Immunopharmacology, 36(2-3), 1997, pp. 173-177
Authors:
NEUHOF C
SOEFFKER G
CERNAIANU G
DAPPER F
TILLMANNS H
NEUHOF H
Citation: C. Neuhof et al., EFFECT OF BRADYKININ B2-RECEPTOR ANTAGONISM ON POSTISCHEMIC CORONARY REPERFUSION, Immunopharmacology, 36(2-3), 1997, pp. 179-183